544611 — Mahamaya Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Mahamaya Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7.78	13.7	30.4	30.1	39.2
Net Total Accounts Receivable
Net Total Receivables	100	132	160	324	516
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	239	333	540	873	1,567
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	165	171	178	183	217
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	441	557	779	1,121	1,883
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	201	300	477	780	1,315
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	309	400	584	873	1,389
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	132	157	194	248	494
Total Liabilities & Shareholders' Equity	441	557	779	1,121	1,883
Total Common Shares Outstanding